{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:53:49Z","timestamp":1782730429576,"version":"3.54.5"},"reference-count":40,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12,1]]},"DOI":"10.1210\/en.2006-1559","type":"journal-article","created":{"date-parts":[[2007,9,6]],"date-time":"2007-09-06T20:48:03Z","timestamp":1189111683000},"page":"6047-6053","source":"Crossref","is-referenced-by-count":43,"title":["Cardiac Hypertrophy Caused by Peroxisome Proliferator- Activated Receptor-\u03b3 Agonist Treatment Occurs Independently of Changes in Myocardial Insulin Signaling"],"prefix":"10.1210","volume":"148","author":[{"given":"Sandra","family":"Sena","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, and Program in Human Molecular Biology and Genetics (S.S., I.R.R., A.R.W., H.A.T., N.W., R.O.P., E.D.A.), University of Utah, School of Medicine, Salt Lake City, Utah 84112;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac R.","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, and Program in Human Molecular Biology and Genetics (S.S., I.R.R., A.R.W., H.A.T., N.W., R.O.P., E.D.A.), University of Utah, School of Medicine, Salt Lake City, Utah 84112;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam R.","family":"Wende","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, and Program in Human Molecular Biology and Genetics (S.S., I.R.R., A.R.W., H.A.T., N.W., R.O.P., E.D.A.), University of Utah, School of Medicine, Salt Lake City, Utah 84112;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred P.","family":"McQueen","sequence":"additional","affiliation":[{"name":"Division of Cardiology (A.P.M., S.E.L.), University of Utah School of Medicine, Salt Lake City, Utah 84132;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Theobald","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, and Program in Human Molecular Biology and Genetics (S.S., I.R.R., A.R.W., H.A.T., N.W., R.O.P., E.D.A.), University of Utah, School of Medicine, Salt Lake City, Utah 84112;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Wilde","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, and Program in Human Molecular Biology and Genetics (S.S., I.R.R., A.R.W., H.A.T., N.W., R.O.P., E.D.A.), University of Utah, School of Medicine, Salt Lake City, Utah 84112;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Oliveira","family":"Pereira","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, and Program in Human Molecular Biology and Genetics (S.S., I.R.R., A.R.W., H.A.T., N.W., R.O.P., E.D.A.), University of Utah, School of Medicine, Salt Lake City, Utah 84112;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon E.","family":"Litwin","sequence":"additional","affiliation":[{"name":"Division of Cardiology (A.P.M., S.E.L.), University of Utah School of Medicine, Salt Lake City, Utah 84132;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel P.","family":"Berger","sequence":"additional","affiliation":[{"name":"Department of Metabolic Disorders (J.P.B.), Merck Research Laboratories, Rahway, New Jersey 07065"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Dale","family":"Abel","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism and Diabetes, and Program in Human Molecular Biology and Genetics (S.S., I.R.R., A.R.W., H.A.T., N.W., R.O.P., E.D.A.), University of Utah, School of Medicine, Salt Lake City, Utah 84112;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041120564152000_R1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","article-title":"The mechanisms of action of PPARs.","volume":"53","author":"Berger","year":"2002","journal-title":"Annu Rev Med"},{"key":"2019041120564152000_R2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/endo.143.3.8662","article-title":"Induction of adipocyte complement-related protein of 30 kilodaltons by PPAR\u03b3 agonists: a potential mechanism of insulin sensitization.","volume":"143","author":"Combs","year":"2002","journal-title":"Endocrinology"},{"key":"2019041120564152000_R3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/414821a","article-title":"New drug targets for type 2 diabetes and the metabolic syndrome.","volume":"414","author":"Moller","year":"2001","journal-title":"Nature"},{"key":"2019041120564152000_R4","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1172\/JCI18730","article-title":"Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPAR\u03b1, \u03b2\/\u03b4, and \u03b3.","volume":"114","author":"Li","year":"2004","journal-title":"J Clin Invest"},{"key":"2019041120564152000_R5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.ATV.21.3.365","article-title":"Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice.","volume":"21","author":"Collins","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041120564152000_R6","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1161\/01.CIR.0000103683.99399.7E","article-title":"Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. October 7, 2003.","volume":"108","author":"Nesto","year":"2003","journal-title":"Circulation"},{"key":"2019041120564152000_R7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0065-3233(01)56006-4","article-title":"Peroxisome proliferator-activated receptor (PPAR) \u03b3 agonists for diabetes.","volume":"56","author":"Moller","year":"2001","journal-title":"Adv Protein Chem"},{"key":"2019041120564152000_R8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.RES.0000179226.34112.6d","article-title":"Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-\u03b3 both induce cardiac hypertrophy in mice.","volume":"97","author":"Duan","year":"2005","journal-title":"Circ Res"},{"key":"2019041120564152000_R9","doi-asserted-by":"crossref","first-page":"37670","DOI":"10.1074\/jbc.M204572200","article-title":"Akt signaling mediates postnatal heart growth in response to insulin and nutritional status.","volume":"277","author":"Shiojima","year":"2002","journal-title":"J Biol Chem"},{"key":"2019041120564152000_R10","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1093\/emboj\/19.11.2537","article-title":"The conserved phosphoinositide 3-kinase pathway determines heart size in mice.","volume":"19","author":"Shioi","year":"2000","journal-title":"EMBO J"},{"key":"2019041120564152000_R11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1172\/JCI0213946","article-title":"Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression.","volume":"109","author":"Belke","year":"2002","journal-title":"J Clin Invest"},{"key":"2019041120564152000_R12","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1073\/pnas.1934654100","article-title":"Phosphoinositide 3-kinase(p110\u03b1) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy.","volume":"100","author":"McMullen","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041120564152000_R13","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1074\/jbc.M310405200","article-title":"The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110\u03b1) pathway.","volume":"279","author":"McMullen","year":"2004","journal-title":"J Biol Chem"},{"key":"2019041120564152000_R14","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1161\/CIRCULATIONAHA.105.595231","article-title":"Akt1 is required for physiological cardiac growth.","volume":"113","author":"DeBosch","year":"2006","journal-title":"Circulation"},{"key":"2019041120564152000_R15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/01.RES.0000109415.17511.18","article-title":"Calcineurin\/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.","volume":"94","author":"Wilkins","year":"2004","journal-title":"Circ Res"},{"key":"2019041120564152000_R16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0014-2999(99)00932-2","article-title":"Troglitazone does not initiate hypertrophy but can sensitise cardiomyocytes to growth effects of serum.","volume":"390","author":"Bell","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"2019041120564152000_R17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1046\/j.1365-2362.1996.2880577.x","article-title":"The effects of hyperinsulinaemia on myocardial mass, blood pressure regulation and central haemodynamics in rats.","volume":"26","author":"Holmang","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"2019041120564152000_R18","doi-asserted-by":"crossref","first-page":"H787","DOI":"10.1152\/ajpheart.00974.2005","article-title":"Hyperinsulinemia: effect on cardiac mass\/function, angiotensin II receptor expression, and insulin signaling pathways","volume":"291","author":"Samuelsson","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019041120564152000_R19","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/sj.bjp.0702932","article-title":"Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution.","volume":"128","author":"Pickavance","year":"1999","journal-title":"Br J Pharmacol"},{"key":"2019041120564152000_R20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1440-1681.2004.03954.x","article-title":"An antidiabetic thiazolidinedione induces eccentric cardiac hypertrophy by cardiac volume overload in rats.","volume":"31","author":"Arakawa","year":"2004","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2019041120564152000_R21","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1073\/pnas.0501744102","article-title":"Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention.","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041120564152000_R22","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nm1278","article-title":"Thiazolidinediones expand body fluid volume through PPAR\u03b3 stimulation of ENaC-mediated renal salt absorption.","volume":"11","author":"Guan","year":"2005","journal-title":"Nat Med"},{"key":"2019041120564152000_R23","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.yjmcc.2005.07.017","article-title":"Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density.","volume":"39","author":"McQueen","year":"2005","journal-title":"J Mol Cell Cardiol"},{"key":"2019041120564152000_R24","doi-asserted-by":"crossref","first-page":"H1261","DOI":"10.1152\/ajpheart.00108.2003","article-title":"Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload","volume":"285","author":"Hu","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019041120564152000_R25","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1210\/en.2004-0321","article-title":"Peroxisome proliferator-activated receptor \u03b3 agonism increases the capacity for sympathetically mediated thermogenesis in lean and ob\/ob mice.","volume":"145","author":"Sell","year":"2004","journal-title":"Endocrinology"},{"key":"2019041120564152000_R26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2337\/diabetes.52.2.291","article-title":"PPAR-gamma activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion.","volume":"52","author":"Laplante","year":"2003","journal-title":"Diabetes"},{"key":"2019041120564152000_R27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/med.1025","article-title":"Peroxisome proliferator-activated receptor (PPAR) modulators: diabetes and beyond.","volume":"21","author":"Jones","year":"2001","journal-title":"Med Res Rev"},{"key":"2019041120564152000_R28","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1210\/en.2005-0938","article-title":"Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.","volume":"146","author":"Buchanan","year":"2005","journal-title":"Endocrinology"},{"issue":"2 Pt 1","key":"2019041120564152000_R29","first-page":"E187","article-title":"Hemodynamic actions of insulin","volume":"267","author":"Baron","year":"1994","journal-title":"Am J Physiol"},{"key":"2019041120564152000_R30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.HYP.0000200042.64517.19","article-title":"Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction.","volume":"47","author":"Salas","year":"2006","journal-title":"Hypertension"},{"key":"2019041120564152000_R31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1152\/physiolgenomics.00226.2004","article-title":"Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats.","volume":"21","author":"Kong","year":"2005","journal-title":"Physiol Genomics"},{"key":"2019041120564152000_R32","doi-asserted-by":"crossref","first-page":"10086","DOI":"10.1073\/pnas.0603615103","article-title":"Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-\u03b3 coactivator 1\u03b1.","volume":"103","author":"Arany","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 2","key":"2019041120564152000_R33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1113\/jphysiol.2003.045104","article-title":"Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles","volume":"551","author":"Garnier","year":"2003","journal-title":"J Physiol"},{"key":"2019041120564152000_R34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1440-1681.2002.03655.x","article-title":"Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart.","volume":"29","author":"Lehman","year":"2002","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2019041120564152000_R35","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11906-004-0036-2","article-title":"Energy substrate metabolism in cardiac hypertrophy.","volume":"6","author":"Allard","year":"2004","journal-title":"Curr Hypertens Rep"},{"key":"2019041120564152000_R36","doi-asserted-by":"crossref","first-page":"H1055","DOI":"10.1152\/ajpheart.00925.2003","article-title":"Regular exercise is associated with a protective metabolic phenotype in the rat heart","volume":"287","author":"Burelle","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019041120564152000_R37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejphar.2006.03.058","article-title":"PPARgamma agonist induced cardiac enlargement is associated with reduced fatty acid and increased glucose utilization in myocardium of Wistar rats.","volume":"538","author":"Edgley","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"2019041120564152000_R38","doi-asserted-by":"crossref","first-page":"25050","DOI":"10.1074\/jbc.M401028200","article-title":"Cardiac-specific knockout of lipoprotein lipase alters plasma lipoprotein triglyceride metabolism and cardiac gene expression.","volume":"279","author":"Augustus","year":"2004","journal-title":"J Biol Chem"},{"key":"2019041120564152000_R39","doi-asserted-by":"crossref","first-page":"8716","DOI":"10.1074\/jbc.M509890200","article-title":"Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction.","volume":"281","author":"Augustus","year":"2006","journal-title":"J Biol Chem"},{"key":"2019041120564152000_R40","doi-asserted-by":"crossref","first-page":"E331","DOI":"10.1152\/ajpendo.00298.2002","article-title":"Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA","volume":"284","author":"Augustus","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/148\/12\/6047\/10727000\/endo6047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T03:43:49Z","timestamp":1555040629000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/148\/12\/6047\/2502087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,1]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2006-1559","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,1]]}}}